Wilmer Cutler Pickering Hale and Dorr advised MKS Instruments, Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the initial purchasers. MKS...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Sunrun Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the initial purchasers. Sunrun Inc. (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Tenaya Therapeutics on the transaction, and Davis Polk & Wardwell advised the underwriters. Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage...
You must be a Standard 1 Year member to access this content.
Sidley Austin represented Atara Biotherapeutics, Inc. in the offering, and Davis Polk & Wardwell represented TD Cowen, as the sales agent. Atara Biotherapeutics, Inc. (Nasdaq:ATRA) (“Atara”)...
You must be a Standard 1 Year member to access this content.
K&L Gates advised AVITA, and Davis Polk advised the sales agent for the offering. AVITA Medical, Inc. announced the establishment of an SEC-registered at-the-market program of...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher advised Amazon.com, while Davis Polk advised the representatives of the underwriters in the offering. Amazon.com, Inc. executed its offering, consisting of $1.25...
You must be a Standard 1 Year member to access this content.
Davis Polk advised EnVen Energy Corporation, while Vinson & Elkins advised Talos on the deal. EnVen Energy Corporation announced its $1.1 billion acquisition by Talos Energy Inc....
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented IDEAYA, while Davis Polk advised the representatives of the several underwriters in the offering. IDEAYA Biosciences, Inc. (Nasdaq: IDYA) announced the pricing of an...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Senti Biosciences, while Davis Polk advised Dynamics Special Purpose Corp. on the deal. Senti Biosciences (“Senti Bio”) announced its definitive business combination agreement with...
You must be a Standard 1 Year member to access this content.
Simpson Thacher represented First Advantage, while Davis Polk advised the representatives of the several underwriters in the offering. First Advantage announced the $345 million secondary offering of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Xponential Fitness in its IPO, while Latham & Watkins represented the underwriters. Xponential Fitness, Inc. executed its $120 million initial public offering of 10,000,000...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Aligos Therapeutics, while Davis Polk advised the representatives of the several underwriters in the offering. Aligos Therapeutics, Inc. (Nasdaq: ALGS) announced...
You must be a Standard 1 Year member to access this content.
